Hinge Health HNGE
NYSE HNGE
$92.45 +1.63 (+1.79%)
At close: Sep 4, 2026 · 4:00 PM EDT

Hinge Health (HNGE) Long-Term Investments (2025 - 2026)

Hinge Health's (HNGE) quarterly Long-Term Investments came in at $84.7 million in Q2 2026, down 5.6% quarter-over-quarter from $89.8 million in Q1 2026.

Analysis

Hinge Health (HNGE) Long-Term Investments (2025 - 2026) Analysis & Trends

Hinge Health has disclosed Long-Term Investments across 2 years of filings, most recently posting $84.7 million for Q2 2026.

  • In Q2 2026, Long-Term Investments changed N/A year-over-year to $84.7 million; the TTM figure through Jun 2026 stood at $84.7 million (changed N/A YoY), while the FY2025 annual figure was $113.2 million, changed N/A from the prior year.
  • Long-Term Investments came in at $84.7 million for Q2 2026 at Hinge Health, down from $89.8 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $113.2 million in Q4 2025 to a low of $15.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Hinge Health 7.41 Bn 7.03 Bn 183.95 Mn 84.74 Mn
2 Hims & Hers Health 6.47 Bn 5.63 Bn 480.80 Mn -
3 Ethos Technologies 2.54 Bn 2.37 Bn 185.54 Mn 84.54 Mn
4 Omada Health 1.38 Bn 1.16 Bn 63.79 Mn -
5 Teladoc Health 1.14 Bn 366.41 Mn 416.09 Mn -
6 Talkspace 870.58 Mn 779.48 Mn 24.80 Mn -
7 Akso Health 259.44 Mn 259.25 Mn - -
8 LifeMD 147.29 Mn 147.29 Mn - -
9 eHealth 31.71 Mn -69.34 Mn - -
10 Mangoceuticals 7.39 Mn 7.14 Mn 44,215.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 84.74 Mn
Mar 31, 2026 89.77 Mn
Dec 31, 2025 113.17 Mn
Sep 30, 2025 15.08 Mn